Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionhistone phosphatase activity

EYA2 EYA3

1.59e-0431462GO:0140789
GeneOntologyMolecularFunctionhistone H2AXY142 phosphatase activity

EYA2 EYA3

1.59e-0431462GO:0140793
GeneOntologyBiologicalProcesspositive regulation of DNA repair

EYA4 EYA2 EYA3 ARID1A RUVBL2 TMEM161A ARID1B SPIDR

8.68e-061431478GO:0045739
GeneOntologyBiologicalProcesspositive regulation of DNA metabolic process

PRKD2 EYA4 ATR EYA2 EYA3 ARID1A RUVBL2 PPP1R10 TMEM161A ARID1B SPIDR

2.77e-0533314711GO:0051054
GeneOntologyBiologicalProcessregulation of DNA repair

EYA4 ATR EYA2 EYA3 ARID1A RUVBL2 TMEM161A ARID1B SPIDR

4.73e-052341479GO:0006282
DomainARM-like

ATR LRRK2 ARFGEF2 KPNA6 HUWE1 MEI1 ARID1A PPP4R4 ARID1B NF1 UTP20 HEATR5B

1.79e-0627014912IPR011989
DomainEYA_dom

EYA4 EYA2 EYA3

1.98e-0641493IPR006545
DomainEYA_fam

EYA4 EYA2 EYA3

1.98e-0641493IPR028472
DomainARM-type_fold

RALGAPA1 ATR LRRK2 ARFGEF2 NCBP1 KPNA6 HUWE1 MEI1 ARID1A PPP4R4 NF1 UTP20 HEATR5B

3.36e-0633914913IPR016024
Domain-

KDM5A KDM5C ARID1A ARID1B

4.96e-061514941.10.150.60
DomainBRIGHT

KDM5A KDM5C ARID1A ARID1B

4.96e-06151494SM00501
DomainARID_dom

KDM5A KDM5C ARID1A ARID1B

4.96e-06151494IPR001606
DomainARID

KDM5A KDM5C ARID1A ARID1B

4.96e-06151494PS51011
DomainARID

KDM5A KDM5C ARID1A ARID1B

4.96e-06151494PF01388
Domain-

ATR LRRK2 ARFGEF2 KPNA6 ARID1A PPP4R4 ARID1B NF1 UTP20 HEATR5B

1.19e-05222149101.25.10.10
DomainBAF250/Osa

ARID1A ARID1B

6.32e-0521492IPR021906
DomainBAF250_C

ARID1A ARID1B

6.32e-0521492IPR033388
DomainA1A_glycop

ORM1 ORM2

6.32e-0521492IPR001500
DomainBAF250_C

ARID1A ARID1B

6.32e-0521492PF12031
DomainLys_sp_deMease-like_dom

KDM5A KDM5C

3.75e-0441492IPR013637
DomainPLU-1

KDM5A KDM5C

3.75e-0441492PF08429
Domainzf-C5HC2

KDM5A KDM5C

6.22e-0451492PF02928
DomainZnf_C5HC2

KDM5A KDM5C

6.22e-0451492IPR004198
Pubmed

Comparative interactome analysis of α-arrestin families in human and Drosophila.

ATP6AP1 COPA KDM5C NCBP1 HUWE1 RUVBL2 NF1 MAGED4 FANCI SCRIB ARRDC2

1.38e-073131511138270169
Pubmed

Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.

RALGAPA1 EYA4 LZTR1 ATP6AP1 COPA TTC27 NCBP1 KPNA6 HUWE1 EYA2 ARID1A PPP4R4 PPP1R10 ARID1B C2CD3 FANCI DDX54 SCRIB PHLPP2

1.63e-0710491511927880917
Pubmed

EYA4, a novel vertebrate gene related to Drosophila eyes absent.

EYA4 EYA2 EYA3

1.59e-06615139887327
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

PRKD2 LZTR1 KDM5A ABCA12 KDM5C WRNIP1 TTC27 BPIFB1 KPNA6 SRCAP ARID1A RUVBL2 ARAF ITIH4 ARID1B ZFHX4 SCRIB BRD1

1.85e-0611161511831753913
Pubmed

ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.

DGCR2 ATP6AP1 ATR COPA SLC39A1 PIGS ARFGEF2 ST3GAL4 GDE1 TMEM161A FBN1 NF1 FANCI CD59 UTP20 SCRIB RFT1 IGSF3

5.11e-0612011511835696571
Pubmed

The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.

KDM5A KDM5C CHD2 SRCAP ARID1A RUVBL2 ARID1B

5.98e-06157151730186101
Pubmed

CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI.

ARFGEF2 TTC27 ARAF NF1 FANCI EXOC2

6.48e-06104151631240132
Pubmed

A proteomic analysis of ataxia telangiectasia-mutated (ATM)/ATM-Rad3-related (ATR) substrates identifies the ubiquitin-proteasome system as a regulator for DNA damage checkpoints.

ATR HUWE1 FANCI

9.41e-0610151317478428
Pubmed

Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.

ATR COPA WRNIP1 ARFGEF2 NCBP1 HUWE1 ARID1A RUVBL2 NF1 FANCI SCRIB EXOC2

9.80e-065821511220467437
Pubmed

C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.

RALGAPA1 DMXL2 ATP6AP1 SLC26A2 PIGS ARFGEF2 NBAS TMEM161A LRIG1 DDX54 HEATR5B

1.38e-055041511134432599
Pubmed

Distal promoter regions are responsible for differential regulation of human orosomucoid-1 and -2 gene expression and acute phase responses.

ORM1 ORM2

1.87e-052151224389491
Pubmed

A new strategy for identification of N-glycosylated proteins and unambiguous assignment of their glycosylation sites using HILIC enrichment and partial deglycosylation.

ORM1 ORM2

1.87e-052151215253437
Pubmed

Selective binding of coumarin enantiomers to human alpha1-acid glycoprotein genetic variants.

ORM1 ORM2

1.87e-052151216290938
Pubmed

Retinoids increase alpha-1 acid glycoprotein expression at the transcriptional level through two distinct DR1 retinoic acid responsive elements.

ORM1 ORM2

1.87e-052151215157739
Pubmed

Orosomucoid-1 Arises as a Shared Altered Protein in Two Models of Multiple Sclerosis.

ORM1 ORM2

1.87e-052151237949310
Pubmed

Comparison of alpha-1-acid glycoprotein isoforms from healthy and cancer patients by capillary IEF.

ORM1 ORM2

1.87e-052151217987628
Pubmed

Reduction and fragmentation of elastic fibers in the skin of obese mice is associated with altered mRNA expression levels of fibrillin-1 and neprilysin.

FBN1 MME

1.87e-052151227892729
Pubmed

α1-Acid Glycoprotein Enhances the Immunosuppressive and Protumor Functions of Tumor-Associated Macrophages.

ORM1 ORM2

1.87e-052151234210751
Pubmed

Orosomucoid 1 promotes colorectal cancer progression and liver metastasis by affecting PI3K/AKT pathway and inducing macrophage M2 polarization.

ORM1 ORM2

1.87e-052151237640741
Pubmed

An acute phase protein α1-acid glycoprotein mitigates AKI and its progression to CKD through its anti-inflammatory action.

ORM1 ORM2

1.87e-052151233846468
Pubmed

Transcriptome Analysis Uncovers a Growth-Promoting Activity of Orosomucoid-1 on Hepatocytes.

ORM1 ORM2

1.87e-052151228927749
Pubmed

α1-Acid glycoprotein decreases neutrophil migration and increases susceptibility to sepsis in diabetic mice.

ORM1 ORM2

1.87e-052151222415874
Pubmed

Structure of 1 -acid glycoprotein. The complete amino acid sequence, multiple amino acid substitutions, and homology with the immunoglobulins.

ORM1 ORM2

1.87e-05215124711474
Pubmed

Structure and expression of the genes coding for human alpha 1-acid glycoprotein.

ORM1 ORM2

1.87e-05215122822385
Pubmed

Adipocytokine orosomucoid integrates inflammatory and metabolic signals to preserve energy homeostasis by resolving immoderate inflammation.

ORM1 ORM2

1.87e-052151220442402
Pubmed

Orosomucoid1: Involved in vascular endothelial growth factor-induced blood-brain barrier leakage after ischemic stroke in mouse.

ORM1 ORM2

1.87e-052151225264156
Pubmed

Molecular characterization and acute phase expression of the multiple Mus caroli alpha 1-acid glycoprotein (AGP) genes. Differences in glucocorticoid stimulation and regulatory elements between the rat and mouse AGP genes.

ORM1 ORM2

1.87e-05215122354997
Pubmed

Structural heterogeneity of glycoform of alpha-1 Acid glycoprotein in alcoholic cirrhosis patients.

ORM1 ORM2

1.87e-052151225408356
Pubmed

Nucleotide sequence of the mouse alpha 1-acid glycoprotein gene 1.

ORM1 ORM2

1.87e-05215123676251
Pubmed

Structure and characterisation of a duplicated human alpha 1 acid glycoprotein gene.

ORM1 ORM2

1.87e-05215122970990
Pubmed

The disulfide bonds of alpha1-acid glycoprotein.

ORM1 ORM2

1.87e-05215124603214
Pubmed

Dissecting the role of SWI/SNF component ARID1B in steady-state hematopoiesis.

ARID1A ARID1B

1.87e-052151237611161
Pubmed

Subunits of ARID1 serve as novel biomarkers for the sensitivity to immune checkpoint inhibitors and prognosis of advanced non-small cell lung cancer.

ARID1A ARID1B

1.87e-052151232791957
Pubmed

Role of Nlrp6 and Nlrp12 in the maintenance of intestinal homeostasis.

NLRP12 NLRP6

1.87e-052151224338634
Pubmed

Orm2 Deficiency Aggravates High-Fat Diet-Induced Obesity through Gut Microbial Dysbiosis and Intestinal Inflammation.

ORM1 ORM2

1.87e-052151237853937
Pubmed

Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers.

ARID1A ARID1B

1.87e-052151228967863
Pubmed

A mouse gene family associated with a major submaxillary-gland glycoprotein.

ORM1 ORM2

1.87e-05215123977853
Pubmed

Structure and expression of mouse alpha 1-acid glycoprotein gene-3 (AGP-3).

ORM1 ORM2

1.87e-05215121605854
Pubmed

C5aR plus MEK inhibition durably targets the tumor milieu and reveals tumor cell phagocytosis.

NF1 C5AR1

1.87e-052151238458648
Pubmed

Analysis of the five glycosylation sites of human alpha 1-acid glycoprotein.

ORM1 ORM2

1.87e-05215121567356
Pubmed

Plasma alpha-1-acid glycoprotein as a potential predictive biomarker for non-haematological adverse events of docetaxel in breast cancer patients.

ORM1 ORM2

1.87e-052151228554261
Pubmed

Dual ARID1A/ARID1B loss leads to rapid carcinogenesis and disruptive redistribution of BAF complexes.

ARID1A ARID1B

1.87e-052151234386776
Pubmed

Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma.

ARID1A ARID1B

1.87e-052151223202128
Pubmed

ARID1 proteins: from transcriptional and post-translational regulation to carcinogenesis and potential therapeutics.

ARID1A ARID1B

1.87e-052151233890484
Pubmed

Evidence for the existence of multiple alpha 1-acid glycoprotein genes in the mouse.

ORM1 ORM2

1.87e-05215123003086
Pubmed

ARAF protein kinase activates RAS by antagonizing its binding to RASGAP NF1.

ARAF NF1

1.87e-052151235613620
Pubmed

Interaction of acute-phase-inducible and liver-enriched nuclear factors with the promoter region of the mouse alpha 1-acid glycoprotein gene-1.

ORM1 ORM2

1.87e-05215121371400
Pubmed

Structure of human alpha1-acid glycoprotein and its high-affinity binding site.

ORM1 ORM2

1.87e-052151212480518
Pubmed

ARID1B is a specific vulnerability in ARID1A-mutant cancers.

ARID1A ARID1B

1.87e-052151224562383
Pubmed

Orosomucoid in liver diseases.

ORM1 ORM2

1.87e-052151234963738
Pubmed

Genetic variations of orosomucoid genes associated with serum alpha-1-acid glycoprotein level and the pharmacokinetics of paclitaxel in Japanese cancer patients.

ORM1 ORM2

1.87e-052151221638284
Pubmed

The bile acid induced hepatokine orosomucoid suppresses adipocyte differentiation.

ORM1 ORM2

1.87e-052151233168190
Pubmed

Mitigation of non-alcoholic steatohepatitis via recombinant Orosomucoid 2, an acute phase protein modulating the Erk1/2-PPARγ-Cd36 pathway.

ORM1 ORM2

1.87e-052151237355990
Pubmed

Molecular cloning of cDNAs corresponding to two genes of alpha 1-acid glycoprotein and characterization of two alleles of AGP-1 in the mouse.

ORM1 ORM2

1.87e-05215122475311
Pubmed

ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma.

ARID1A ARID1B

1.87e-052151229890703
Pubmed

A synthetic retinoic acid receptor agonist Am80 ameliorates renal fibrosis via inducing the production of alpha-1-acid glycoprotein.

ORM1 ORM2

1.87e-052151232651445
Pubmed

Ectodomain shedding of CD200 from the B-CLL cell surface is regulated by ADAM28 expression.

ADAM28 CD200

1.87e-052151223643150
Pubmed

SLC46A1 Haplotype with Predicted Functional Impact has Prognostic Value in Breast Carcinoma.

SLC46A1 SLCO1A2

1.87e-052151233387348
Pubmed

SWI/SNF factors required for cellular resistance to DNA damage include ARID1A and ARID1B and show interdependent protein stability.

ARID1A ARID1B

1.87e-052151224788099
Pubmed

Isoform differentiation of intact AGP from human serum by capillary electrophoresis-mass spectrometry.

ORM1 ORM2

1.87e-052151220617306
Pubmed

Establishment and characterization of VOA1066 cells: An undifferentiated endometrial carcinoma cell line.

ARID1A ARID1B

1.87e-052151233052929
Pubmed

alpha 1-Acid glycoprotein binds human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein via N-linked glycans.

ORM1 ORM2

1.87e-05215127795416
Pubmed

Investigation of genetic variants of alpha-1 acid glycoprotein by ultra-performance liquid chromatography-mass spectrometry.

ORM1 ORM2

1.87e-052151219018521
Pubmed

Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas.

ARID1A ARID1B

1.87e-052151227562491
Pubmed

Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.

RPP30 WRNIP1 KPNA6 HUWE1 SRCAP ARID1A ARID1B NF1 DDX54 SCRIB

2.43e-054401511034244565
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

ATR COPA KDM5A KDM5C WRNIP1 ARFGEF2 HUWE1 JUND NF1 FAM13A UTP20 SCRIB EXOC2

3.57e-057741511315302935
Pubmed

Defining the membrane proteome of NK cells.

COPA PIGS KATNB1 WRNIP1 ARFGEF2 KPNA6 ST3GAL4 HUWE1 PRKRA NBAS NF1 CLCN5 FANCI DDX54 EXOC2 HEATR5B

5.19e-0511681511619946888
Pubmed

Dynamics of expression of ARID1A and ARID1B subunits in mouse embryos and in cells during the cell cycle.

ARID1A ARID1B

5.60e-053151221647563
Pubmed

CEP120 interacts with C2CD3 and Talpid3 and is required for centriole appendage assembly and ciliogenesis.

C2CD3 CEP120

5.60e-053151230988386
Pubmed

Effect of mannosylated derivatives on HIV-1 infection of macrophages and lymphocytes.

ORM1 ORM2

5.60e-05315129455924
Pubmed

RBP2 belongs to a family of demethylases, specific for tri-and dimethylated lysine 4 on histone 3.

KDM5A KDM5C

5.60e-053151217320161
Pubmed

KDM5 family of demethylases promotes CD44-mediated chemoresistance in pancreatic adenocarcinomas.

KDM5A KDM5C

5.60e-053151237880235
Pubmed

A human homologue of the Drosophila eyes absent gene underlies branchio-oto-renal (BOR) syndrome and identifies a novel gene family.

EYA2 EYA3

5.60e-05315129020840
Pubmed

Interaction of human tRNA-dihydrouridine synthase-2 with interferon-induced protein kinase PKR.

PRKRA DUS2

5.60e-053151218096616
Pubmed

Mapping of a putative genetic locus determining ethanol intake in the mouse.

ORM1 ORM2

5.60e-05315123676756
Pubmed

Immunoglobulin D enhances the release of tumor necrosis factor-alpha, and interleukin-1 beta as well as interleukin-1 receptor antagonist from human mononuclear cells.

ORM1 ORM2

5.60e-05315128774350
Pubmed

Mouse alpha-1-microglobulin/bikunin precursor: cDNA analysis, gene evolution and physical assignment of the gene next to the orosomucoid locus.

ORM1 ORM2

5.60e-05315127689339
Pubmed

Histone demethylase KDM5 regulates cardiomyocyte maturation by promoting fatty acid oxidation, oxidative phosphorylation, and myofibrillar organization.

KDM5A KDM5C

5.60e-053151238230606
Pubmed

Differential interactions and structural stability of chitosan oligomers with human serum albumin and α-1-glycoprotein.

ORM1 ORM2

5.60e-053151224359035
Pubmed

ARID1A, ARID1B, and ARID2 Mutations Serve as Potential Biomarkers for Immune Checkpoint Blockade in Patients With Non-Small Cell Lung Cancer.

ARID1A ARID1B

5.60e-053151234512623
Pubmed

Loss of ARID1B and SMARCB1 expression are specific for the diagnosis of dedifferentiated/undifferentiated carcinoma in tumours of the upper gynaecological tract and cervix.

ARID1A ARID1B

5.60e-053151233432679
Pubmed

Dephosphorylation of the C-terminal tyrosyl residue of the DNA damage-related histone H2A.X is mediated by the protein phosphatase eyes absent.

EYA2 EYA3

5.60e-053151219351884
Pubmed

Eyes absent represents a class of protein tyrosine phosphatases.

EYA2 EYA3

5.60e-053151214628052
Pubmed

Protection by alpha 1-acid glycoprotein against tumor necrosis factor-induced lethality.

ORM1 ORM2

5.60e-05315127931089
Pubmed

TNPO1-mediated nuclear import of ARID1B promotes tumor growth in ARID1A-deficient gynecologic cancer.

ARID1A ARID1B

5.60e-053151234044070
Pubmed

Genome-Wide Transcriptional Regulation Mediated by Biochemically Distinct SWI/SNF Complexes.

ARID1A ARID1B

5.60e-053151226716708
Pubmed

Dexamethasone regulation of alpha 1-acid glycoprotein and other acute phase reactants in rat liver and hepatoma cells.

ORM1 ORM2

5.60e-05315126184374
Pubmed

Human alpha1-acid glycoprotein binds to CCR5 expressed on the plasma membrane of human primary macrophages.

ORM1 ORM2

5.60e-053151211336643
Pubmed

Regulation of the Fanconi Anemia DNA Repair Pathway by Phosphorylation and Monoubiquitination.

ATR FANCI

5.60e-053151234828369
Pubmed

Fatigue-induced Orosomucoid 1 Acts on C-C Chemokine Receptor Type 5 to Enhance Muscle Endurance.

ORM1 ORM2

5.60e-053151226740279
Pubmed

Identification of a new acute phase protein.

ORM1 ORM2

5.60e-05315127545679
Pubmed

Characterization of a Linked Jumonji Domain of the KDM5/JARID1 Family of Histone H3 Lysine 4 Demethylases.

KDM5A KDM5C

5.60e-053151226645689
Pubmed

The genetic control of sialadenitis versus arthritis in a NOD.QxB10.Q F2 cross.

ORM1 ORM2

5.60e-053151211782015
Pubmed

Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome.

ARID1A ARID1B

5.60e-053151222426308
Pubmed

Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer.

ARID1A ARID1B

5.60e-053151224382590
Pubmed

The hepatic orosomucoid/α1-acid glycoprotein gene cluster is regulated by the nuclear bile acid receptor FXR.

ORM1 ORM2

5.60e-053151223861371
Pubmed

Differential expression of the mouse alpha 1-acid glycoprotein genes (AGP-1 and AGP-2) during inflammation and aging.

ORM1 ORM2

5.60e-05315122054382
Pubmed

A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection.

KPNA6 PRKRA

5.60e-053151220064372
Pubmed

A probability-based approach for high-throughput protein phosphorylation analysis and site localization.

EYA4 COPA KDM5C HUWE1 ARAF PPP1R10 DFFA FAM13A FANCI SCRIB

7.46e-055031511016964243
Pubmed

E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.

USP17L7 GPR37 NCBP1 CHD2 ST3GAL4 HUWE1 PCDH17 FRY DEFB121 UTP20 SCRIB BANK1

9.50e-057361511229676528
GeneFamilyEYA transcriptional coactivator and phosphatases

EYA4 EYA2 EYA3

9.22e-07411231044
GeneFamilyAT-rich interaction domain containing

KDM5A KDM5C ARID1A ARID1B

1.81e-06151124418
GeneFamilySolute carriers

SLC39A1 SLC35D2 SLC26A2 SLC46A1 SLC9C2 SLC9C1 SLCO1A2 SLC25A38 SLC16A10

7.85e-043951129752
GeneFamilyINO80 complex |SRCAP complex

SRCAP RUVBL2

1.33e-03911221329
ToppCellPBMC-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

LRRK2 DRC1 NCF4 ALPK1 ORM1 RETN ZDHHC19 MME PLCG2 C5AR1

1.06e-0919015110cb62ece5929896dfba30a4f563c6ba5a5712b71e
ToppCellPBMC-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

LRRK2 DRC1 NCF4 ALPK1 ORM1 RETN ZDHHC19 MME PLCG2 C5AR1

1.06e-0919015110fedd266198d294d8da8c9e217e5e0cb8b2e1b566
ToppCellPBMC-Mild-Myeloid-Neutrophil-Neutrophil|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

LRRK2 DRC1 NCF4 GCGR ALPK1 ORM1 PLET1 MME

1.20e-081261518ec32bfd6cd93fbe02f7577893c82b04d209a52e7
ToppCellCOVID-19_Severe-Myeloid_G|COVID-19_Severe / Disease group, lineage and cell class

LRRK2 DRC1 NCF4 ALPK1 ORM1 RETN ZDHHC19 MME C5AR1

1.86e-0819015198a81cb90273c361e9fdfaa0a31806da253fa1388
ToppCellPBMC-Mild-Myeloid-Neutrophil-Neutrophil|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

LRRK2 DRC1 NCF4 GCGR ALPK1 ORM1 PLET1 MME

1.95e-0813415187b237690a3765d974f6f813ef2d01154bc23b9d6
ToppCelldroplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPR22 SLC26A2 SNX20 ARFGEF2 CLCN5 ZFHX4 BANK1 PHLPP2

1.08e-071671518f5bffa77061baec0ba87bd688a047595f32534db
ToppCellPBMC-Mild-Myeloid-Neutrophil|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

LRRK2 DRC1 NCF4 GCGR ORM1 PLET1 MME

3.29e-071311517fdec4e31ffeb02615ccb7097758a8218dd1f8c1c
ToppCellCOVID-19_Mild-Myeloid_G-Neutrophil|COVID-19_Mild / Disease group, lineage and cell class

LRRK2 NCF4 GCGR ALPK1 ORM1 PLET1 MME

4.03e-071351517e9eb2bebb6d19c439c83f46c12ca0d676db69de8
ToppCellcontrol-Neutrophil|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

NLRP12 DMXL2 COPA LRRK2 ARID1A JUND FAM13A C5AR1

4.27e-072001518b5d197472799cc61d7497faed91ac2564ae4930a
ToppCell5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

NLRP12 LRRK2 DRC1 ORM1 ORM2 RETN C5AR1

2.05e-061721517cf46810dd1072b6f2171e5d9530351ddc79a055b
ToppCell10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue

RALGAPA1 CHD2 HUWE1 PPP1R10 ARID1B NF1 FAM13A

3.69e-061881517ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCellprimary_auditory_cortex_(A1C)-Non-neuronal-Macroglial|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

COL9A2 SLC35D2 GPR37 EYA2 ZFHX4 SLCO1A2 KCNJ10

3.83e-061891517784ace2be87f2ecb19490f4974f63a559516e0eb
ToppCellSomatosensory_Cortex_(S1)-Non-neuronal-Macroglial|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

COL9A2 SLC35D2 GPR37 EYA2 ZFHX4 SLCO1A2 KCNJ10

3.96e-06190151707f21386ea6eb23416a537d2250e3042efe93fb0
ToppCellPBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

DRC1 NCF4 ORM1 ORM2 FBN1 RETN PLCG2

4.10e-0619115176c1283d51a845cff67ed5e500f7e944165297b53
ToppCellSmart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

LRRK2 NCF4 ALPK1 ORM1 RETN MME C5AR1

4.10e-061911517d4f77c73311d1149466bbfe4adbd6a301946ec90
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)

ARFGEF2 CHD2 JUND MME PLCG2 BRD1 BANK1

4.10e-0619115171ecd9849d14d5ebf3daf610e83fb50820cafd3ed
ToppCellPBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

DRC1 NCF4 ORM1 ORM2 FBN1 RETN PLCG2

4.24e-06192151786d561c30554ff04c21801d4aaf8e3c9efe49af4
ToppCellCOVID-19_Severe-Myeloid_G-immature_Neutrophil|COVID-19_Severe / Disease group, lineage and cell class

DRC1 NCF4 ORM1 ORM2 FBN1 RETN PLCG2

4.24e-061921517303deb68da2e4a75e6ee5a79478182a8bc41c7c5
ToppCellPCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

COL9A2 EYA4 EYA2 JUND CLCN5 ZFHX4 SRGAP1

4.24e-061921517d0649410cf5eacdb0c1dce70e37c7473ef5fddfa
ToppCellSmart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

LRRK2 NCF4 ALPK1 ORM1 RETN MME C5AR1

4.39e-061931517e1855cff9a6bcfda9188b9fdf6c9d698405da990
ToppCellCOVID_vent-Myeloid-Monocytic-Neutrophil|COVID_vent / Disease condition, Lineage, Cell class and subclass

LRRK2 NCF4 ALPK1 ORM1 ZDHHC19 MME C5AR1

4.54e-061941517eb23b171e429165dd26a64377eae7fa2ce25f547
ToppCellBronchus_Control_(B.)|World / Sample group, Lineage and Cell type

EYA4 SLC26A2 BPIFB1 ADAM28 SYNJ2 PLCG2 BANK1

5.02e-061971517b6dff2ee108813e18657e2d8cf850e2423f8c8e9
ToppCellCOVID-19_Severe-immature_Neutrophil|COVID-19_Severe / Disease condition and Cell class

ORM1 ORM2 FBN1 RETN FANCI CD59 PLCG2

5.37e-061991517f82fa9d651e78f9ebbe6264e00a48c54b1786a69
ToppCellCOVID-19_Severe-immature_Neutrophil-|COVID-19_Severe / Disease condition and Cell class

ORM1 ORM2 FBN1 RETN FANCI CD59 PLCG2

5.37e-06199151742ea0c19c455bdb0ae89b428d09c333104c670dc
ToppCellControl-Control-Myeloid-Neutrophil|Control / Disease, condition lineage and cell class

LRRK2 NCF4 ALPK1 NLRP6 ORM1 MME C5AR1

5.55e-06200151795c41f147a1594d49e73cb56d86d301c3115ce20
ToppCell10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

LRRK2 NCF4 ALPK1 ORM1 ZDHHC19 MME C5AR1

5.55e-0620015176beabd5bad042d4d65c89c2f537c7376230f7c08
ToppCell10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

LRRK2 NCF4 ALPK1 ORM1 ZDHHC19 MME C5AR1

5.55e-062001517026495aa7f1e7528a01d9199475cfc393677fc60
ToppCellCOVID-19_Mild-Myeloid_G|COVID-19_Mild / Disease group, lineage and cell class

LRRK2 NCF4 GCGR ORM1 PLET1 MME

9.09e-061421516c8aeb747ed836197265d269aa131fae172b45aec
ToppCellPBMC-Mild-Myeloid-Neutrophil|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

LRRK2 NCF4 GCGR ORM1 PLET1 MME

9.46e-061431516974260c25dad599eea83a33e83117f7307b92a42
ToppCellfacs-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l8|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

NLRP12 DMXL2 SNX20 NCF4 RETN C5AR1

1.20e-0514915160f9d2209e8a02371b9f93c0a2fb6f79a4ce48ef1
ToppCellfacs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL9A2 ALPK1 EYA2 MSS51 PHLPP2 SLC16A10

1.24e-05150151647ea08d7609e1d2382bf56ef9e5c767e3597cf93
ToppCell3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VIPR2 CARMIL3 UNC13D ZFHX4 SCN7A MSS51

1.24e-051501516909ccab92855f5f049dc29593aadab1ea973297b
ToppCellfacs-Lung-Endomucin-24m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NLRP12 SNX20 NCF4 RETN CLCN5 C5AR1

1.67e-0515815160ed844ab625351a46b74edddf082279ed1bae5c6
ToppCellfacs-Lung-Endomucin-24m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NLRP12 SNX20 NCF4 RETN CLCN5 C5AR1

1.67e-051581516b3a810314e253b4fd0f578e759c36fdd21722934
ToppCellPBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

FAM174B DRC1 ORM1 RETN ZDHHC19 C5AR1

1.86e-051611516f5da03c426f3124ea302bd343b6bca81cafee858
ToppCellPBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

FAM174B DRC1 ORM1 RETN ZDHHC19 C5AR1

1.92e-0516215164e3bf16799c6552366d4c7e42b1328a05dcad7e7
ToppCellfacs-Brain_Non-Myeloid-Hippocampus-3m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SNX20 NCF4 SCN7A CD300LG C5AR1 SLC16A10

1.99e-0516315168028636632c168dc50731d0ebecaf88a70daf81d
ToppCellLPS-IL1RA-Epithelial_airway-Club_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL9A2 EYA4 ADAM28 PPP4R4 MME EPHX3

2.13e-0516515161a114eacaab598f755a173a3fed842ba91f689dd
ToppCellLPS-IL1RA-Epithelial_airway-Club_cells-Airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL9A2 EYA4 ADAM28 PPP4R4 MME EPHX3

2.13e-0516515169cfd3c1d2c6d714fde83b90465f1f9741b0e50ce
ToppCellLPS-IL1RA+antiTNF-Epithelial_airway-Club_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL9A2 EYA4 BPIFB1 ADAM28 PPP4R4 MME

2.44e-0516915168c96e1baa38ec5e777e627ab9dbce025e771f2c0
ToppCellLPS-IL1RA+antiTNF-Epithelial_airway-Club_cells-Airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL9A2 EYA4 BPIFB1 ADAM28 PPP4R4 MME

2.44e-05169151686041be5d3aeab5b9269f7912791b944f325a1b4
ToppCellsevere_influenza-Neutrophil|severe_influenza / disease group, cell group and cell class (v2)

FAM174B DRC1 ORM1 ZDHHC19 MME C5AR1

2.78e-051731516615e266419b9f06e964eff73cb466f05451ba0dd
ToppCellsevere_influenza-Neutrophil|World / disease group, cell group and cell class (v2)

LRRK2 DRC1 ORM1 ZDHHC19 MME C5AR1

2.87e-051741516f9f07436b7d3f190800cd85d229f007032f391e1
ToppCelldroplet-Kidney-KIDNEY-30m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CENPT SLC35D2 BPIFB1 EYA3 ADAM28 PLET1

2.97e-05175151631f0fb2e47e357dbf9c15436b7df85b3c370ded7
ToppCell(03)_Secretory-(4)_1wkpi|(03)_Secretory / shred by cell type and Timepoint

SLC26A2 ITIH4 PPP1R10 JUND FBN1 LRIG1

2.97e-05175151606b52f85baa31b55bb31477244892b6da79fe2c9
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NLRP12 EYA4 SLC9C1 RFT1 EPHX3

3.07e-0510615158cae594c91b61dc5b12d27e44e68de71956dfff7
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

EYA4 SLC26A2 CHD2 ADAM28 SRGAP1 PLCG2

3.37e-0517915166e965e424eebef50f0202cff75f458be395cfca1
ToppCellfacs-Skin-Anagen-3m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABCA12 ORM1 DFFA MAPKAPK3 EPHX3 MVK

3.37e-0517915164a072526c3a524a7aed99bdb32a07a1ce1f48972
ToppCellCOVID-19_Severe-Neutrophil-|COVID-19_Severe / Disease condition and Cell class

LRRK2 NCF4 PPP1R10 ZDHHC19 MME C5AR1

3.58e-0518115165e5101195d5ff8c8ea7ddcf0bc4f4e03e64c01e0
ToppCellCOVID-19_Severe-Neutrophil|COVID-19_Severe / Disease condition and Cell class

LRRK2 NCF4 PPP1R10 ZDHHC19 MME C5AR1

3.58e-051811516aa5e5fb0308b5e2ef918548c85529c9a433c57f5
ToppCell10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue

RALGAPA1 CHD2 HUWE1 PPP1R10 ARID1B LRIG1

3.58e-051811516f2315414e714ac86211546a935660c4be6e85f1b
ToppCellfacs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

VIPR2 COL13A1 PPP4R4 FBN1 FAM13A MME

3.70e-051821516c557de6ccd327c46e0a5423cd9936d78e0abae5f
ToppCellfacs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

VIPR2 COL13A1 PPP4R4 FBN1 FAM13A MME

3.70e-051821516dbe4b2557cf19e0682ed446f8397d3a1153642f0
ToppCelldroplet-Liver-Npc-21m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL9A2 EYA2 PTCHD4 ABCC8 PLET1 CD200

3.81e-05183151699ab7a43527eb226027efbcd8c0b6a8e46fc3c93
ToppCelldroplet-Liver-Npc-21m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL9A2 EYA2 PTCHD4 ABCC8 PLET1 CD200

3.81e-05183151628916f0597690ff534578be2cb715b485cb1de1a
ToppCellSmart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

NLRP12 NCF4 ORM1 ORM2 ZDHHC19 MME

3.93e-0518415167ecdf2645e9378cf2f5ce4557f2cf100e6f184ba
ToppCellCOVID_non-vent-Myeloid-Monocytic-Neutrophil|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

LRRK2 NCF4 ALPK1 ORM1 MME C5AR1

4.05e-0518515162c89af7cdf5306b900a5b8ec4fdfb8210e5667ed
ToppCellControl-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class

BPIFB1 ADAM28 FBN1 SYNJ2 SRGAP1 MME

4.05e-0518515166814b3c94c7558443c038a227b5c8563d2cfeac4
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

EYA4 COL13A1 FBN1 CEP120 LRIG1 SCN7A

4.05e-0518515169f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Granulocytic-Neutrophil-Neu_c3-CST7|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

LRRK2 DRC1 ORM1 ZDHHC19 MME C5AR1

4.05e-05185151697f8a644f51c02a5f8a74d8c923ad637a15ed06d
ToppCellPCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

COL9A2 EYA4 COL13A1 FBN1 LRIG1 SCN7A

4.17e-0518615164d68ee3d32f7ef884faf402ef92b31b0eb4656f1
ToppCellwk_20-22-Hematologic-Myeloid-Myelocyte-like|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

NLRP12 SNX20 NCF4 ORM1 RETN C5AR1

4.17e-05186151653b4ce33ae6fa32f1b56cbc62b1d7915e935afc9
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

EYA4 COL13A1 FBN1 CEP120 LRIG1 SCN7A

4.30e-05187151613731298bc562ec29582f5da1b4c97261284f6f1
ToppCellPrimary_Visual_cortex_(V1C)-Non-neuronal-Macroglial|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

COL9A2 SLC35D2 GPR37 ZFHX4 SLCO1A2 KCNJ10

4.30e-05187151697e520705491c8f52a32025311a9fa7b9176979a
ToppCellAnterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

COL9A2 SLC35D2 GPR37 ZFHX4 SLCO1A2 KCNJ10

4.43e-051881516d9692b6048d9b85524a07a1807bdd4757731c151
ToppCellMid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

COL9A2 SLC35D2 EYA2 ZFHX4 SLCO1A2 KCNJ10

4.43e-051881516505b6b4277d7dea87aee27191d0acca67928b8e6
ToppCellPBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

DRC1 NCF4 ORM1 ORM2 RETN PLCG2

4.56e-0518915163b35022c0619df6db234613aa53a076899ca9562
ToppCellPBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

DRC1 NCF4 ORM1 ORM2 RETN PLCG2

4.56e-051891516358ff514f1c8aa46067208ddf1b68396d789c130
ToppCell10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

LRRK2 ORM1 ORM2 ZDHHC19 MME C5AR1

4.56e-051891516235c24eeab5139f5821fccd5c879d8787682f4ef
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

NLRP12 DMXL2 LRRK2 JUND RETN C5AR1

4.56e-05189151655aba1ebc012006a5db3ff9c92589cb3d9f7c68a
ToppCellprimary_auditory_cortex_(A1C)-Non-neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

COL9A2 SLC35D2 EYA2 ZFHX4 SLCO1A2 KCNJ10

4.56e-05189151637ecbd73408d462b47d7e5611f203143e08a2689
ToppCellAnterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

COL9A2 SLC35D2 EYA2 ZFHX4 SLCO1A2 KCNJ10

4.70e-0519015162de8e4cfeee350a9a76af749d6ce58d948c129b8
ToppCellPCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_monocyte_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

NLRP12 LRRK2 NCF4 ORM1 RETN C5AR1

4.70e-051901516b7ce76931edc6734b80ddbb2fca23b098a8c1352
ToppCellwk_20-22-Hematologic-Myeloid-Neutrophil|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

NLRP12 LRRK2 ORM1 ORM2 RETN C5AR1

4.70e-0519015165da4a90f56f66567614d84b9b437f559006ea51c
ToppCellPrimary_Motor_Cortex_(M1)-Non-neuronal-Macroglial|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

COL9A2 SLC35D2 GPR37 ZFHX4 SLCO1A2 KCNJ10

4.70e-051901516ae97df1b06bcd46c05759b53c35dc8fea97f4ac1
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Granulocytic|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

DMXL2 LRRK2 DRC1 ORM1 MME C5AR1

4.84e-05191151678ede1f15484414a2a54a2f0f0cb6abe0c6b6513
ToppCell10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

LRRK2 BPIFB1 NCF4 ORM1 ZDHHC19 MME

4.84e-051911516b9b091d6b352d5128bb864ff52d2e5fb3387b766
ToppCellMid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

COL9A2 SLC35D2 GPR37 ZFHX4 SLCO1A2 KCNJ10

4.84e-0519115162110a1dd10730ad7ee7a265fb1716ab3ddafcf4a
ToppCellPrimary_Motor_Cortex_(M1)-Non-neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

COL9A2 SLC35D2 GPR37 ZFHX4 SLCO1A2 KCNJ10

4.84e-0519115162b056cbe2e82e056e1f798974999378460eb1d16
ToppCellAnterior_Cingulate_gyrus_(CgG)-Non-neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

COL9A2 SLC35D2 EYA2 ZFHX4 SLCO1A2 KCNJ10

4.84e-051911516f3158cedf67e3b90aa94ea1f61c72c33aaa2d5ba
ToppCellMid-temporal_gyrus_(MTG)-Non-neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

COL9A2 SLC35D2 EYA2 ZFHX4 SLCO1A2 KCNJ10

4.84e-051911516a90c8ab2077e52bbc998457c85a1b9867f9c8c93
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Granulocytic-Neutrophil|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

DMXL2 LRRK2 DRC1 ORM1 MME C5AR1

4.84e-051911516d049ab9abd5f8d497eb7e3ccb39b28283298bc65
ToppCellPBMC-Mild-Myeloid-Neutrophil-Neutrophil-Neu_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

LRRK2 GCGR ALPK1 ORM1 MME

4.93e-051171515089793a950e8593b4acc1ba6a5e5474682f5fda6
ToppCellPBMC-Mild-Myeloid-Neutrophil-Neutrophil-Neu_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

LRRK2 GCGR ALPK1 ORM1 MME

4.93e-0511715153d98d77b4725d684e7496059e8b0ffffbe40301d
ToppCellPCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_monocyte_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

NLRP12 LRRK2 ORM1 ORM2 RETN C5AR1

4.98e-051921516d44f46352bac414b45cc749f7cbdc3a159bd7ae8
ToppCelldroplet-Fat-Scat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

STEAP2 FBN1 ZFHX4 SRGAP1 SCN7A MME

5.12e-051931516316ebdf15f75d88c348f909b643fcd315364ca84
ToppCelldroplet-Fat-Scat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

STEAP2 FBN1 ZFHX4 SRGAP1 SCN7A MME

5.12e-0519315161afdd3f7d703f4204a2cbfe40e135ac7b09213f7
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

DMXL2 LRRK2 NCF4 RETN CLCN5 C5AR1

5.12e-051931516d845beb0915a5b4bbd1e8f9b8d9322527a822849
ToppCell3'-GW_trimst-1-LargeIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SNX20 LRRK2 NCF4 ORM1 RETN C5AR1

5.12e-051931516db26b79dfe9c48388f6b64dceb21073d104ab504
ToppCelldroplet-Fat-Scat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

STEAP2 FBN1 ZFHX4 SRGAP1 SCN7A MME

5.12e-0519315168dc6db335678f3a5cfd36026ad811fed8d9cb4bc
ToppCell10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

NLRP12 DMXL2 WIPI1 LRRK2 ORM1 C5AR1

5.27e-051941516e2d0dfb92356fa7ad7008aa8ac4198e2ac5d2495
ToppCelldroplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COPA CARMIL3 HUWE1 JUND ABCC8 RNF182

5.27e-0519415160b023de48ed8a550d169bbe954881eb04bf4f981
ToppCell10x5'-lymph-node_spleen-Lymphocytic_B-ABC_aged-B_memory|lymph-node_spleen / Manually curated celltypes from each tissue

LRRK2 NCF4 ADAM28 DUS2 PLCG2 BANK1

5.27e-051941516b57ae94a092b58623a244a258b4659a3864542c7
ToppCellSmart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

GABBR2 FBN1 ABCC8 ZDHHC19 MME C5AR1

5.43e-051951516d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCellmild-Myeloid-Neutrophils_3|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

NLRP12 LRRK2 NCF4 ORM1 MME C5AR1

5.43e-051951516a1cfed0092debcc003eff6a62508556b7664d5e1
ToppCellSmart-seq2-bone_marrow_(Smart-seq2)-myeloid|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

NLRP12 DMXL2 LRRK2 JUND RETN C5AR1

5.43e-051951516b0dbaae86f5703ab62f925e0f36500274044884a
ToppCellSmart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

GABBR2 FBN1 ABCC8 ZDHHC19 MME C5AR1

5.43e-05195151619853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCelldroplet-Liver-LIVER-NPC-1m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL13A1 FAM174B PCDH17 SRGAP1 CD300LG IGSF3

5.43e-051951516126f46dd15dddcf5701144718bb8ba1ce84b2d1d
ToppCellfacs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC39A1 JUND FRY LRIG1 CD200 IGSF3

5.43e-0519515165ed995717bd3d35cd66442e6e84fe18fe0f7cf96
ToppCellTracheal-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

SNX20 ADCY7 FRY RETN OR1L6 MME

5.43e-051951516c96755d2eb98112b703b5dbee9c88730ace7dcbf
DrugThiethylperazine malate [52239-63-1]; Up 200; 6uM; MCF7; HT_HG-U133A

DMXL2 COL13A1 TAPBPL KATNB1 EYA3 NF1 SYNJ2 SLCO1A2 GYG2 BANK1 CD200

9.54e-08199151113576_UP
DrugRaloxifene hydrochloride [82640-04-8]; Up 200; 7.8uM; MCF7; HT_HG-U133A

VIPR2 WIPI1 KDM5A KDM5C ARFGEF2 GABBR2 ARID1A JUND SYNJ2 MVK

7.42e-07195151106235_UP
DrugNSC651714

ARAF ITIH4 ORM1 ORM2

5.29e-06181514CID000003839
Drugestradiol, USP; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA

ABCA12 FAM174B ST3GAL4 SRCAP JUND TMEM161A GYG2 SPIDR MVK

6.66e-0619615191021_DN
DrugClozapine [5786-21-0]; Down 200; 12.2uM; HL60; HT_HG-U133A

COPA TAPBPL JUND FRY NF1 DDX54 C5AR1 MVK PHLPP2

6.66e-0619615191289_DN
DrugDiloxanide furoate [3736-81-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A

DMXL2 LZTR1 SRCAP ARID1A PPP4R4 ZFHX4 GYG2 C5AR1 SLC16A10

6.93e-0619715193399_DN
DrugSulfasalazine [599-79-1]; Up 200; 10uM; MCF7; HT_HG-U133A

TAPBPL ST3GAL4 HUWE1 SRCAP GABBR2 NF1 ZFHX4 GYG2 BANK1

7.52e-0619915192882_UP
DrugNitrofurantoin [67-20-9]; Up 200; 16.8uM; HL60; HT_HG-U133A

COL13A1 KDM5A ST3GAL4 SRCAP NF1 SLCO1A2 DDX54 CD59 MVK

7.52e-0619915192341_UP
DrugNSC-639187

DGCR2 ATP6AP1 ARAF

9.82e-0671513CID000368342
Drugtertatolol

HTR1D WRNIP1 ORM1 ORM2

1.24e-05221514CID000036920
DrugSL 75102

HTR1D GABBR2 ORM1 ORM2

1.78e-05241514CID005751746
DrugMK 287

ORM1 ORM2 C5AR1

3.32e-05101513CID000131925
DrugAmitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; HL60; HT_HG-U133A

DMXL2 ALPK1 DUS2 DFFA C2CD3 NF1 SYNJ2 DDX54

3.78e-0518815181865_DN
DrugPiperine [94-62-2]; Down 200; 14uM; PC3; HT_HG-U133A

PRKD2 LPAR4 WNT1 KDM5C EYA3 SRCAP GABBR2 JUND

4.23e-0519115184247_DN
Drugnorlorcainide

ORM1 ORM2

4.37e-0521512CID000162188
Drugcarocainide

ORM1 ORM2

4.37e-0521512CID000071970
Drug2,4,4-trimethyl-2-pentanol

ORM1 ORM2

4.37e-0521512CID000094740
Drug3-phenylindole

ORM1 ORM2

4.37e-0521512CID000096502
DrugRemoxipride Hydrochloride [73220-03-8]; Down 200; 9.8uM; HL60; HT_HG-U133A

PRKD2 LZTR1 KDM5C KATNB1 ST3GAL4 ORM2 CLCN5 CD59

4.55e-0519315183124_DN
DrugTerbutaline hemisulfate [23031-32-5]; Down 200; 7.2uM; PC3; HT_HG-U133A

DGCR2 COL13A1 SLC35D2 ALPK1 NF1 FAM13A SLCO1A2 PLCG2

4.55e-0519315185764_DN
DrugEtofylline [519-37-9]; Up 200; 17.8uM; PC3; HT_HG-U133A

DGCR2 DPH1 LZTR1 LPAR4 ALPK1 JUND NF1 SYNJ2

4.55e-0519315182093_UP
Drugradicicol, diheterospora chlamydosporia; Down 200; 0.1uM; HL60; HT_HG-U133A

VIPR2 TAPBPL KATNB1 PDZD7 ST3GAL4 JUND CD59 PHLPP2

4.72e-0519415186178_DN
DrugEstrone [53-16-7]; Down 200; 14.8uM; PC3; HT_HG-U133A

LZTR1 ALPK1 ARID1A JUND NF1 DDX54 SPIDR MVK

4.72e-0519415186647_DN
DrugSulmazole [73384-60-8]; Down 200; 14uM; HL60; HT_HG-U133A

RALGAPA1 DGCR2 VIPR2 KDM5C DUS2 RETN SYNJ2 C5AR1

4.90e-0519515182153_DN
Drug17-AAG; Up 200; 0.1uM; MCF7; HG-U133A

VIPR2 GPR37 SRCAP GABBR2 ADCY7 DUS2 TMEM161A MVK

4.90e-051951518221_UP
DrugSolanine alpha [20562-02-1]; Down 200; 4.6uM; HL60; HT_HG-U133A

PRKD2 LZTR1 CENPT KDM5A PDZD7 ORM2 JUND FAM13A

4.90e-0519515182152_DN
DrugDinoprost trometamol [38362-01-5]; Down 200; 8.4uM; HL60; HT_HG-U133A

LPAR4 ST3GAL4 ALPK1 ARID1A SYNJ2 CD59 BANK1 MVK

4.90e-0519515182446_DN
DrugGlipizide [29094-61-9]; Up 200; 9uM; MCF7; HT_HG-U133A

HTR1D ST3GAL4 HUWE1 SRCAP PPP4R4 FBN1 C5AR1 BANK1

4.90e-0519515184991_UP
DrugHydrastine hydrochloride [5936-28-7]; Up 200; 9.6uM; PC3; HT_HG-U133A

VIPR2 SLC39A1 SLC35D2 NCBP1 JUND SYNJ2 SPIDR MVK

4.90e-0519515187309_UP
Drugradicicol, diheterospora chlamydosporia; Up 200; 0.1uM; PC3; HT_HG-U133A

EYA4 NCF4 HUWE1 EYA3 ADCY7 PCDH17 RETN SPIDR

5.08e-0519615184443_UP
DrugSulpiride [15676-16-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A

ABCA12 ALPK1 HUWE1 SRCAP GABBR2 NF1 ZFHX4 GYG2

5.26e-0519715181467_UP
DrugMetrizamide [31112-62-6]; Up 200; 5uM; MCF7; HT_HG-U133A

DMXL2 COL13A1 ST3GAL4 SRCAP FBN1 GYG2 CACNA1H CD200

5.26e-0519715184156_UP
DrugBetulinic acid [472-15-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A

HTR1D COL13A1 LPAR4 SRCAP GABBR2 FBN1 SYNJ2 EPHX3

5.26e-0519715184181_UP
DrugScopolamin-N-oxide hydrobromide [6106-81-6]; Up 200; 10uM; PC3; HT_HG-U133A

LPAR4 WNT1 ADAM28 PPP4R4 FAM13A SYNJ2 SPIDR MVK

5.26e-0519715186335_UP
DrugMefexamide hydrochloride [3413-64-7]; Up 200; 12.6uM; MCF7; HT_HG-U133A

DGCR2 SLC35D2 GPR37 KATNB1 NCBP1 HUWE1 NBAS SLC16A10

5.26e-0519715187478_UP
DrugMethacholine chloride [62-51-1]; Up 200; 20.4uM; PC3; HT_HG-U133A

RALGAPA1 COL9A2 ALPK1 HUWE1 EYA3 FRY SLCO1A2 PLCG2

5.26e-0519715185773_UP
DrugTridihexethyl chloride; Down 200; 11.4uM; MCF7; HT_HG-U133A

WIPI1 KDM5A KDM5C ARFGEF2 MAPKAPK3 SPIDR BRD1 SLC16A10

5.46e-0519815185486_DN
DrugTridihexethyl chloride; Down 200; 11.4uM; HL60; HT_HG-U133A

SRCAP ADAM28 ORM2 JUND RETN NF1 SYNJ2 CD59

5.46e-0519815182964_DN
DrugMexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; HL60; HT_HG-U133A

DPH1 CENPT GPR22 KDM5C KPNA6 DUS2 NF1 PHLPP2

5.46e-0519815182364_DN
DrugAmpicillin trihydrate [7177-48-2]; Up 200; 10uM; HL60; HG-U133A

RALGAPA1 DGCR2 ATR KATNB1 NCBP1 SRCAP TMEM161A SYNJ2

5.46e-0519815182030_UP
DrugRanitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A

DPH1 KDM5A NCBP1 ALPK1 SRCAP PPP4R4 NF1 CLCN5

5.46e-0519815182251_DN
DrugCyclopentolate hydrochloride [5870-29-1]; Down 200; 12.2uM; HL60; HT_HG-U133A

DGCR2 VIPR2 WIPI1 TAPBPL ARFGEF2 EYA3 SRCAP PHLPP2

5.65e-0519915186132_DN
DrugLysergol [602-85-7]; Down 200; 15.8uM; HL60; HT_HG-U133A

DPH1 COL9A2 ORM2 JUND NF1 DDX54 EXOC2 MVK

5.65e-0519915181325_DN
DrugThiamine hydrochloride [67-03-8]; Up 200; 11.8uM; MCF7; HT_HG-U133A

DMXL2 EYA3 SRCAP FRY NF1 GYG2 CACNA1H PLCG2

5.86e-0520015182894_UP
DrugEpirizole [18694-40-1]; Down 200; 17uM; MCF7; HT_HG-U133A

DGCR2 WIPI1 LZTR1 SLC35D2 LRIG1 SYNJ2 SPIDR BRD1

5.86e-0520015181681_DN
DrugYohimbinic acid monohydrate [27801-27-2]; Down 200; 11.2uM; PC3; HT_HG-U133A

HTR1D LPAR4 FAM174B EYA3 SRCAP DUS2 JUND NF1

5.86e-0520015184082_DN
DrugF-OH

ORM1 ORM2 NF1 SRGAP1 MVK

6.19e-05631515CID000123334
Drugasperflavin

HTR1D ORM1 ORM2

1.23e-04151513CID000004724
Drugdidesmethylimipramine

ORM1 ORM2

1.31e-0431512CID000159642
Drug4-hydroxytertatolol

ORM1 ORM2

1.31e-0431512CID000163871
Drugphomactin A

ATP6AP1 C5AR1

1.31e-0431512CID006444168
DrugMD 770222

ORM1 ORM2

1.31e-0431512CID000129805
Drugp-hydroxyketorolac

ORM1 ORM2

1.31e-0431512CID003082630
Drug1-decyl-3-(N,N-diethylcarbamoyl)piperidine

ORM1 ORM2

1.31e-0431512CID000120652
Drugibuprofenyl-CoA

ORM1 ORM2

1.31e-0431512CID003081818
Drugfluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A_EA

WIPI1 KDM5C JUND TMEM161A LRIG1 DDX54 MVK

1.38e-0416915171075_UP
DrugDAPTA

VIPR2 ITIH4 MME

1.50e-04161513CID000184644
Druggeldanamycin; Up 200; 1uM; MCF7; HT_HG-U133A_EA

PRKD2 WIPI1 KDM5A SLC26A2 KATNB1 SRCAP ADCY7

1.65e-041741517972_UP
DrugPrenylamine lactate [69-43-2]; Up 200; 9.6uM; PC3; HT_HG-U133A

WIPI1 WNT1 EYA3 GABBR2 PPP4R4 JUND C5AR1

2.04e-0418015175070_UP
Drug17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A

DMXL2 GPR37 SRCAP ADCY7 PPP4R4 FBN1 PHLPP2

2.11e-0418115175578_UP
DrugLY 294002; Down 200; 10uM; HL60; HT_HG-U133A

COL9A2 LZTR1 TTC27 SRCAP ORM1 RETN SLC16A10

2.49e-0418615176198_DN
Drugtrifluoperazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A_EA

VIPR2 KDM5C KATNB1 SRCAP NF1 CLCN5 LRIG1

2.49e-0418615171004_UP
DrugClioquinol [130-26-7]; Up 200; 13uM; MCF7; HT_HG-U133A

LZTR1 COL13A1 GPR22 EYA3 SRCAP ADAM28 NF1

2.57e-0418715175258_UP
DrugCGP 51176

HTR1D GABBR2

2.60e-0441512CID005310935
Drugindoloquinolizidine

ORM1 ORM2

2.60e-0441512CID000098358
Drug19,20-epoxycytochalasin Q

ARAF ITIH4

2.60e-0441512CID006479878
DrugAC1L1HWB

ORM1 ORM2

2.60e-0441512CID000004318
Drug6-deoxy-6-fluoro-galactose

ORM1 ORM2

2.60e-0441512CID000165242
Drug3-azanylpropylphosphonous acid

HTR1D GABBR2

2.60e-0441512CID009989268
DrugYM934

ATP6AP1 MME

2.60e-0441512CID000131974
DrugCGP56433

HTR1D GABBR2

2.60e-0441512CID000132966
DrugLovastatin [75330-75-5]; Up 200; 9.8uM; MCF7; HT_HG-U133A

COL9A2 SLC39A1 KDM5A TAPBPL ALPK1 GABBR2 LRIG1

2.66e-0418815172854_UP
DrugAld1.1-H_000455; Up 200; 10uM; PC3; HT_HG-U133A

DPH1 EYA4 LZTR1 EYA3 SRCAP ARID1A JUND

2.92e-0419115177547_UP
DrugClomipramine hydrochloride [17321-77-6]; Up 200; 11.4uM; PC3; HT_HG-U133A

VIPR2 WIPI1 WNT1 ALPK1 EYA3 GABBR2 JUND

2.92e-0419115174487_UP
Drugradicicol; Up 200; 0.1uM; MCF7; HG-U133A

PRKD2 DGCR2 SLC35D2 GPR37 TMEM161A CLCN5 LRIG1

2.92e-041911517489_UP
DrugProglumide [6620-60-6]; Up 200; 12uM; MCF7; HT_HG-U133A

COPA ST3GAL4 HUWE1 SRCAP NF1 ABCC8 PHLPP2

2.92e-0419115173861_UP
Drugpioglitazone HCl; Up 200; 10uM; MCF7; HT_HG-U133A

DGCR2 KPNA6 ST3GAL4 EYA2 SRCAP CACNA1H SPIDR

3.02e-0419215176898_UP
DrugCyclobenzaprine hydrochloride [6202-23-9]; Up 200; 12.8uM; HL60; HT_HG-U133A

DMXL2 LZTR1 PDZD7 ST3GAL4 ORM2 TMEM161A SYNJ2

3.02e-0419215171332_UP
DrugClotrimazole [23593-75-1]; Up 200; 11.6uM; MCF7; HT_HG-U133A

WIPI1 TAPBPL SLC26A2 KATNB1 GCGR SRCAP CACNA1H

3.11e-0419315173166_UP
DrugPyrithyldione [77-04-3]; Down 200; 24uM; PC3; HT_HG-U133A

DGCR2 DPH1 GABBR2 DUS2 NF1 SPIDR BRD1

3.11e-0419315177153_DN
DrugRicinine [524-40-3]; Down 200; 24.4uM; HL60; HT_HG-U133A

KDM5C PDZD7 SRCAP NF1 FAM13A SYNJ2 SPIDR

3.11e-0419315172505_DN
DrugPramoxine hydrochloride [637-58-1]; Up 200; 12.2uM; PC3; HT_HG-U133A

DMXL2 EYA4 SRCAP JUND RETN NF1 GYG2

3.11e-0419315173811_UP
DrugRetrorsine [480-54-6]; Down 200; 11.4uM; HL60; HT_HG-U133A

SLC35D2 ALPK1 SRCAP NF1 SYNJ2 SPIDR MVK

3.11e-0419315172129_DN
DrugGraveoline [485-61-0]; Down 200; 14.4uM; MCF7; HT_HG-U133A

DGCR2 ABCA12 ALPK1 ARID1A GYG2 CACNA1H SPIDR

3.21e-0419415174738_DN
Drug0317956-0000 [391210-11-0]; Down 200; 1uM; MCF7; HT_HG-U133A

GPR37 FAM174B NCF4 ALPK1 HUWE1 SRCAP GABBR2

3.21e-0419415173969_DN
DrugYohimbinic acid monohydrate [27801-27-2]; Up 200; 11.2uM; PC3; HT_HG-U133A

DMXL2 GPR22 ADAM28 PCDH17 NF1 SLCO1A2 CD200

3.21e-0419415174082_UP
DrugHydrocotarnine hydrobromide [5985-00-2]; Up 200; 13.2uM; MCF7; HT_HG-U133A

GPR37 NKX2-8 RETN NF1 ZFHX4 GYG2 PHLPP2

3.21e-0419415176827_UP
DrugNadolol [42200-33-9]; Up 200; 13uM; MCF7; HT_HG-U133A

WIPI1 KATNB1 FBN1 NF1 SYNJ2 CACNA1H SPIDR

3.21e-0419415174139_UP
Drug5252917; Up 200; 14uM; MCF7; HT_HG-U133A_EA

LPAR4 GPR37 EYA3 SRCAP ADCY7 SYNJ2 CACNA1H

3.21e-041941517828_UP
DrugQuinethazone [73-49-4]; Down 200; 13.8uM; PC3; HT_HG-U133A

LZTR1 GPR37 KDM5C ST3GAL4 ALPK1 SRCAP MVK

3.21e-0419415174529_DN
DrugFuraltadone hydrochloride [3759-92-0]; Up 200; 11uM; PC3; HT_HG-U133A

DGCR2 COL9A2 GABBR2 JUND NF1 SYNJ2 SPIDR

3.31e-0419515174313_UP
DrugHippeastrine hydrobromide [22352-41-6]; Down 200; 10uM; HL60; HT_HG-U133A

RALGAPA1 COL9A2 GPR22 PPP4R4 JUND BANK1 MVK

3.31e-0419515172187_DN
Drug(-)-Isoproterenol hydrochloride [5984-95-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A

DGCR2 COPA ABCA12 JUND TMEM161A CLCN5 CACNA1H

3.31e-0419515173571_DN
DrugFamprofazone [22881-35-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A

DGCR2 COPA SLC39A1 SRCAP NF1 ZMYM6 MVK

3.31e-0419515173834_DN
DrugVitexin [3681-93-4]; Down 200; 9.2uM; MCF7; HT_HG-U133A

WIPI1 LZTR1 KDM5A ABCA12 ST3GAL4 ALPK1 JUND

3.31e-0419515172810_DN
DrugHarmaline hydrochloride dihydrate [6027-98-1]; Up 200; 14uM; HL60; HT_HG-U133A

COL9A2 SLC35D2 DUS2 FAM13A ZFHX4 SLCO1A2 CD59

3.31e-0419515172149_UP
DrugCarbarsone [121-59-5]; Up 200; 15.4uM; PC3; HT_HG-U133A

VIPR2 ST3GAL4 HUWE1 ADAM28 PPP4R4 NF1 LRIG1

3.31e-0419515173991_UP
DrugSulfaquinoxaline sodium salt [967-80-6]; Up 200; 12.4uM; HL60; HT_HG-U133A

RALGAPA1 SLC35D2 ST3GAL4 GABBR2 ARID1A PCDH17 FBN1

3.42e-0419615172528_UP
DrugPrednisolone [50-24-8]; Up 200; 11uM; MCF7; HT_HG-U133A

DPH1 WIPI1 KDM5A SLC26A2 NCBP1 SYNJ2 CACNA1H

3.42e-0419615177424_UP
Drug6-Hydroxytropinone [5932-53-6]; Up 200; 25.8uM; PC3; HT_HG-U133A

TAPBPL SRCAP FBN1 NF1 SYNJ2 SPIDR PHLPP2

3.42e-0419615174250_UP
Diseaseeye disease (implicated_via_orthology)

EYA4 EYA2 EYA3

2.40e-0661473DOID:5614 (implicated_via_orthology)
Diseasebranchiootorenal syndrome (implicated_via_orthology)

EYA4 EYA2 EYA3

4.18e-0671473DOID:14702 (implicated_via_orthology)
Diseasedipeptidase 2 measurement

CENPT ITIH4 DUS2

1.42e-05101473EFO_0801528
DiseaseAutoinflammatory disorder

NLRP12 COPA PLCG2 MVK

2.75e-05351474C3860213
Diseaseascending aortic diameter

UNC13D DUS2 FBN1 CEP120 LRIG1 ABCC8

7.48e-051401476EFO_0021787
DiseaseCryopyrin-Associated Periodic Syndromes

MME PLCG2

1.47e-0441472C2316212
Diseasesyndromic X-linked intellectual disability Claes-Jensen type (implicated_via_orthology)

KDM5A KDM5C

1.47e-0441472DOID:0060809 (implicated_via_orthology)
DiseaseChronic Infantile Neurological, Cutaneous, and Articular Syndrome

MME PLCG2

1.47e-0441472C0409818
DiseaseFamilial Cold Autoinflammatory Syndrome 1

MME PLCG2

1.47e-0441472C4551895
DiseaseFamilial cold urticaria

MME PLCG2

1.47e-0441472C0343068
DiseaseFamilial cold autoinflammatory syndrome

NLRP12 PLCG2

1.47e-0441472cv:C0343068
DiseaseMuckle-Wells Syndrome

MME PLCG2

2.44e-0451472C0268390
Diseasecyclin-dependent kinase inhibitor 1b measurement

NLRP12 ITIH4

2.44e-0451472EFO_0020298
DiseasenmrA-like family domain-containing protein 1 measurement

NLRP12 NMRAL1

2.44e-0451472EFO_0801844
DiseaseNeurofibromatosis 3

LZTR1 NF1

2.44e-0451472C0917817
DiseaseMENTAL RETARDATION, AUTOSOMAL DOMINANT 12

ARID1A ARID1B

2.44e-0451472C3281201
DiseaseAutistic Disorder

LZTR1 HTR1D KDM5C GABBR2 NF1 SCN7A CACNA1H

3.48e-042611477C0004352
DiseaseETS domain-containing protein Elk-3 measurement

NLRP12 SLC35D2

3.65e-0461472EFO_0801588
DiseaseWAP four-disulfide core domain protein 3 measurement

NLRP12 SLC35D2

3.65e-0461472EFO_0802220
Diseaseacid ceramidase measurement

NLRP12 SLC35D2

3.65e-0461472EFO_0801339
Diseaselon protease homolog, mitochondrial measurement

NLRP12 SLC35D2

3.65e-0461472EFO_0801771
Diseaseserine protease inhibitor Kazal-type 2 measurement

ORM1 ORM2

3.65e-0461472EFO_0802054
Diseasecancer (implicated_via_orthology)

ARID1A ARAF NKX2-8 ARID1B SCRIB RFT1 MVK

4.08e-042681477DOID:162 (implicated_via_orthology)
DiseaseSeckel syndrome (implicated_via_orthology)

CENPT ATR

5.09e-0471472DOID:0050569 (implicated_via_orthology)
Diseasetoll/interleukin-1 receptor domain-containing adapter protein measurement

NLRP12 ST3GAL4

5.09e-0471472EFO_0802134
Diseaseinterleukin 18 measurement

NLRP12 COL13A1 TTC27 PRR12

5.74e-04761474EFO_0004581
DiseaseProfound Mental Retardation

KDM5A KDM5C PRKRA FRY NF1

6.75e-041391475C0020796
DiseaseMental Retardation, Psychosocial

KDM5A KDM5C PRKRA FRY NF1

6.75e-041391475C0025363
DiseaseMental deficiency

KDM5A KDM5C PRKRA FRY NF1

6.75e-041391475C0917816
Diseaseposterior thigh muscle fat infiltration measurement

EYA4 EYA2 JUND

7.05e-04351473EFO_0020934
Diseasefree cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement

WIPI1 TTC27 ST3GAL4 ARID1A CD300LG BANK1 MVK

8.41e-043031477EFO_0004612, EFO_0020945
Diseasesmoking behavior, BMI-adjusted waist-hip ratio

EYA4 EYA2 JUND FAM13A

9.15e-04861474EFO_0004318, EFO_0007788
Diseasephospholipids:total lipids ratio

WIPI1 ST3GAL4 ARID1A DUS2 CD300LG BANK1

9.96e-042271476EFO_0020946
Diseaseneuroblastoma (is_implicated_in)

ARID1A ARID1B

1.08e-03101472DOID:769 (is_implicated_in)
Diseaseresponse to carboplatin, response to antineoplastic agent

LRIG1 PLCG2

1.08e-03101472GO_0097327, GO_0097328
Diseasecoagulation factor XA measurement

ORM1 ORM2

1.32e-03111472EFO_0020266
Diseaseserine protease 27 measurement

SLC46A1 ST3GAL4

1.57e-03121472EFO_0008280
DiseaseAdenoid Cystic Carcinoma

ST3GAL4 SRCAP ARID1A BRD1

1.60e-031001474C0010606
DiseaseCoffin-Siris syndrome

ARID1A ARID1B

1.85e-03131472C0265338
Diseasecoagulation factor X measurement

ORM1 ORM2

1.85e-03131472EFO_0020265
DiseaseDEAFNESS, AUTOSOMAL RECESSIVE (disorder)

DMXL2 PDZD7

1.85e-03131472C1846647
Diseaseamyotrophic lateral sclerosis (biomarker_via_orthology)

ITIH4 KCNJ10

1.85e-03131472DOID:332 (biomarker_via_orthology)
DiseaseIntellectual Disability

RALGAPA1 KDM5A KDM5C PRKRA PRR12 FRY NF1 ZMYM6

1.86e-034471478C3714756
Diseasecholesteryl esters to total lipids in IDL percentage

ARID1A CD300LG BANK1

2.00e-03501473EFO_0022247
Diseasecognitive function measurement, self reported educational attainment

DMXL2 SLC35D2 ARFGEF2 PCDH17 PRR12 ARID1B BANK1

2.08e-033551477EFO_0004784, EFO_0008354
Diseasesitting height ratio

PRKD2 ARID1B EXOC2

2.12e-03511473EFO_0007118
DiseaseSaldino-Noonan Syndrome

C2CD3 CEP120

2.16e-03141472C0036069
Diseaseglucose-dependent insulinotropic peptide measurement

ADAM28 SLCO1A2 EXOC2

2.36e-03531473EFO_0008464
DiseaseRASopathy

LZTR1 NF1

2.48e-03151472cv:C5555857
Diseasevon Willebrand factor measurement

OR13C5 ST3GAL4 BANK1

2.77e-03561473EFO_0004629
Diseasesyndromic intellectual disability (implicated_via_orthology)

KDM5A KDM5C

2.83e-03161472DOID:0050888 (implicated_via_orthology)
Diseasegalectin-3 measurement

NLRP12 ST3GAL4

2.83e-03161472EFO_0008137
Diseaseankle brachial index

NBAS ARID1B

2.83e-03161472EFO_0003912
Diseasealcohol use disorder (implicated_via_orthology)

VIPR2 KDM5A KDM5C ARID1A ARID1B

3.00e-031951475DOID:1574 (implicated_via_orthology)
Diseasechronic lymphocytic leukemia

PRKD2 GPR37 EXOC2 BANK1

3.01e-031191474EFO_0000095
Diseasecholesterol to total lipids in IDL percentage

ARID1A CD300LG BANK1

3.37e-03601473EFO_0022233
Diseasepulmonary surfactant-associated protein d measurement

NLRP12 FAM13A

3.58e-03181472EFO_0020693
Diseaseuric acid measurement

PRKD2 TTC27 CHD2 ARID1A DUS2 LRIG1 RFT1 KCNK17 SLC16A10

3.60e-036101479EFO_0004761
Diseaseosteochondrodysplasia (is_implicated_in)

COL9A2 SLC26A2

3.99e-03191472DOID:2256 (is_implicated_in)
Diseasepulse pressure measurement

KDM5A FAM174B UNC13D CHD2 ST3GAL4 MEI1 SRCAP STEAP2 ARID1B FBN1 CEP120 FAM13A ZFHX4 LRIG1 BRD1

4.11e-03139214715EFO_0005763
Diseasetotal lipids in very large HDL measurement

WIPI1 CD300LG BANK1

4.41e-03661473EFO_0022312
DiseaseMultiple Epiphyseal Dysplasia

COL9A2 SLC26A2

4.42e-03201472C0026760
Diseaseulcerative colitis, Crohn's disease

ADCY7 CD200

4.42e-03201472EFO_0000384, EFO_0000729
Diseasetriglycerides to phosphoglycerides ratio

ARID1A CD300LG BANK1

4.79e-03681473EFO_0022327
Diseasecholesteryl ester measurement, high density lipoprotein cholesterol measurement

WIPI1 ST3GAL4 ARID1A FAM13A CD300LG MVK

4.85e-033121476EFO_0004612, EFO_0010351
DiseaseST2 protein measurement

ST3GAL4 BANK1

4.86e-03211472EFO_0010599
Diseasetriglyceride measurement, body fat percentage

EYA2 FAM13A

4.86e-03211472EFO_0004530, EFO_0007800

Protein segments in the cluster

PeptideGeneStartEntry
KLLILSNSLLRDLTP

BANK1

81

Q8NDB2
RKSVLLLLPFTTTSL

FAM200B

596

P0CF97
ELRLTPLTVLLRSVL

BRD1

561

O95696
LQLVKVPISLSIDRL

BPIFB1

216

Q8TDL5
LPVSLLLSVAVSAIK

ADAM28

6

Q9UKQ2
PTLELISETLKRIFL

ABCA12

2131

Q86UK0
ISILLRDLPTLKAAV

FAM174B

81

Q3ZCQ3
VLTVLSLLPLLEAQI

ORM2

6

P19652
LRSKVVSLQLLLSVL

ARFGEF2

401

Q9Y6D5
LSPQRLVLETLCKLS

ARID1B

2146

Q8NFD5
ILTALREKQAPELSL

DFFA

241

O00273
LPTVLLDRKIETLLT

DMXL2

486

Q8TDJ6
VETQPLLRLTLAVLT

ADCY7

661

P51828
LRKSLPSLLRNVLTE

C5AR1

311

P21730
SLSEKTVLLLVTPFL

CD59

106

P13987
VRLLLSEIFPSKLSL

DPH1

321

Q9BZG8
LPSTLIIFTILILLT

MT-ATP6

186

P00846
TSKLLLELPLVIGTI

ARRDC2

291

Q8TBH0
ALLPSELRTLIQEAK

ALPK1

41

Q96QP1
PVRTCSKVLVLLSLL

ITIH4

6

Q14624
LPLIVTLSTISIILL

PCDH17

706

O14917
TKLQTLPVSRITDLL

RFT1

211

Q96AA3
ITTTQLVPALAKVLL

EYA3

481

Q99504
VLSPQRLVLETLSKL

ARID1A

2111

O14497
SLELLPIILTALATK

FANCI

126

Q9NVI1
LNPLLTLLTKSTRLT

KPNA6

211

O60684
FLSLVITPVIRAKLS

SLC46A1

366

Q96NT5
LPTLRSLSQQLLLDI

LZTR1

806

Q8N653
TKDTPRLSLLLVILG

MAGED4

496

Q96JG8
IRLLLKTDPTERLTI

MAPKAPK3

281

Q16644
PLAIVLLIAQLVLTT

KCNJ10

141

P78508
LTLRLSKNRITQLPV

LRIG1

191

Q96JA1
DIELTLRLNPKALTL

NMRAL1

271

Q9HBL8
LLCTVARLLPEKLTI

NCBP1

71

Q09161
SLKRLLTDVLSRPLT

MSS51

231

Q4VC12
TLLLLRDYKIPTLIT

MSS51

371

Q4VC12
VVLRTLRKPATLSQI

LPAR4

226

Q99677
SLLLKNSPLVSRLTL

MDH2

41

P40926
LKLASPELERLIIQS

JUND

96

P17535
SLKLILQRFLPLITD

KATNB1

581

Q9BVA0
SATKLPLEALRALLQ

CARMIL3

431

Q8ND23
ILSPTRELALQTLKF

DDX54

171

Q8TDD1
RELLLDKLLETPSTL

EXOC2

336

Q96KP1
LALIIKLILSQLETP

KCNK17

256

Q96T54
KLLLLQDIRSVVAPT

PDZD7

606

Q9H5P4
QIALTSPLLDSRLQK

CSNKA2IP

266

A0A1B0GTH6
ILLQEIPIRSISLRS

FBXO39

301

Q8N4B4
RLAKSTLTLIPLLGV

GCGR

346

P47871
PLEISLSVLVLLLTI

MME

26

P08473
LSSTPLLKDLLELTR

NCF4

261

Q15080
LPERLTKFLITQILV

PRKD2

646

Q9BZL6
LLLTSGKITLLILDE

LRRK2

141

Q5S007
PRLIKDLLQDLSSTL

FBXO25

166

Q8TCJ0
ISLRELKTILPLINF

PLCG2

161

P16885
QLASLLRLTPTQVKI

NKX2-8

116

O15522
VTTTLFLLTPLLLII

OR13C5

201

Q8NGS8
LLKLFLRELPDSLIT

FAM13A

116

O94988
EKLLRLLSLISIALP

HUWE1

3451

Q7Z6Z7
LLSLISIALPENKVS

HUWE1

3456

Q7Z6Z7
LLLPSLKLLLESRDE

NBAS

2251

A2RRP1
LIESKLLSLLLPLEQ

DRC1

506

Q96MC2
PRLETILSLLVSLQK

KDM5A

1221

P29375
ILSLLVSLQKLPVRL

KDM5A

1226

P29375
VVLFQLLRSIPSILL

MEI1

831

Q5TIA1
ISSILLLLPIFLIST

OR2AE1

201

Q8NHA4
SVPLLLSIVSLVILL

CD200

236

P41217
RKLVVLITPQVSSLL

GYG2

66

O15488
LITPQVSSLLRVILS

GYG2

71

O15488
TIELLQRSLPKIERS

ARAF

566

P10398
LTRTLQVLLPDLAAK

ATR

991

Q13535
LVTTTQLIPALAKVL

EYA4

546

O95677
FLLLVLLLVTRSPVN

GDE1

16

Q9NZC3
SNLLEIRVLQPVTKL

IGSF3

666

O75054
TILPTILFLIARILK

HEATR5B

1776

Q9P2D3
LNSVRLPLLSVKFLT

KLHL28

221

Q9NXS3
LLLALPEVVLRQLSK

GPR37

391

O15354
SRLSKELLLDPQQTL

C2CD3

1696

Q4AC94
EILLSLIRSSGKLIL

CHD2

781

O14647
KPEIRLQSEINLLTL

CEP120

811

Q8N960
VSNKVRILELLPALT

FBN1

2771

P35555
VEKFRSILLSVPLLV

COPA

1026

P53621
LEEQTPRTLLKNILL

CENPT

81

Q96BT3
TLKLRNILDLSPFTV

CLCN5

746

P51795
ASPRSLLVLLQVVVL

COL9A2

6

Q14055
PRTLQALKISLAVVL

HTR1D

31

P28221
LLLFLLVLTVTEPLR

DGCR2

11

P98153
VTALLAPSRLSLKLL

EPHX3

6

Q9H6B9
VLTVLSLLPLLEAQI

ORM1

6

P02763
LEQLRKISLPLYSIL

GABBR2

471

O75899
LTLQLFSLLTPVSKI

FRY

2116

Q5TBA9
ILKLVVSRSASLVLP

FRY

2286

Q5TBA9
PAALRSSQIIALKLL

COL13A1

226

Q5TAT6
SSQIIALKLLPLLNS

COL13A1

231

Q5TAT6
IRILPSLEDTLSLVK

DUS2

156

Q9NX74
LLLTVTLLLAQVTPV

DEFB121

6

Q5J5C9
LLASISEKVRLEILP

GRIP2

316

Q9C0E4
IPLTIVILLLSLESN

GPR22

96

Q99680
LKLVVETLISSLRPI

CACNA1H

1416

O95180
LLSKALLPTALLLVT

NLRP6

311

P59044
LDLNISEKLTLLPTL

RNF180

231

Q86T96
TSLPLLLQTLSRKSR

OR1L6

21

Q8NGR2
VPILLSLVKIFLETR

PIGS

531

Q96S52
VTTTQLIPALAKVLL

EYA2

446

O00167
IKILTRLTIIVSDPS

RPP30

71

P78346
IPIDLLDRLLIVSTT

RUVBL2

346

Q9Y230
KEQSSVLITLLLPFL

UTP20

1346

O75691
TVLRKFTIPLTLLLE

SLC35D2

121

Q76EJ3
IRKLLLTLPRSVLIV

SRGAP1

616

Q7Z6B7
VDLLSLLVPIKISST

TDRG1

41

Q3Y452
VRLSLANEALLPTLI

TAPBPL

306

Q9BX59
TLLSVIEVLPKETLR

PPP4R4

156

Q6NUP7
TLIVLRFLTLLLISP

SLC9C1

336

Q4G0N8
PLILTLNCTLLLKTL

TMEM161A

381

Q9NX61
LLDSTALLVTPRILK

SYNJ2

501

O15056
QLIRCLKSPLETLAL

PRAMEF19

286

Q5SWL8
ILARSKVLVSLVLIL

PTCHD4

231

Q6ZW05
LLLRVLAITSSSIPK

ST3GAL4

96

Q11206
NKTLPIVAITLLSLV

STEAP2

256

Q8NFT2
SSFVPALIILILLRK

SLCO1A2

611

P46721
TELLLTPKRLASLVS

RNF182

106

Q8N6D2
LELRENLLKSLPASL

SCRIB

156

Q14160
VLKRLSLSPALQDAL

PRR12

1896

Q9ULL5
LATTQVKTPIPLLLR

SRCAP

601

Q6ZRS2
STLLFQPLDLLKTRL

SLC25A38

41

Q96DW6
TLRSRLSIILQDPVL

ABCC8

1416

Q09428
VRILAPVLVLLSLLS

CD300LG

246

Q6UXG3
FTVQIRALPILSTLK

PLET1

131

Q6UQ28
ELLLRVLPLQEKLTA

SNX20

206

Q7Z614
ILLSLTRKVLLPDLE

POGLUT3

221

Q7Z4H8
KRLRTTITPEQLEIL

ZFHX4

2561

Q86UP3
LLLQKISVSLPLSLS

LINC00052

21

Q96N35
DSPLKIIQILIATIT

RALGAPA1

1356

Q6GYQ0
LLTEVPVRILSSLSL

PHLPP2

536

Q6ZVD8
ITSLLCLLVLLPTKE

SLC26A2

306

P50443
ERTVLLLQKPLLSVV

SPIDR

736

Q14159
ISSLKRSPALQILLT

MVK

221

Q03426
LASSEQRILKVILLL

SLC39A1

296

Q9NY26
LLTKTAVSRPLFLVL

PSTK

136

Q8IV42
TRALATLKLLSIPLV

YJEFN3

211

A6XGL0
IEATVIALTKLQPLL

NF1

2291

P21359
ELKLNASLPALLLIR

ATP6AP1

166

Q15904
INLLKRSLLSIPNTD

PRKRA

226

O75569
SIIRILLQKLTSPDV

VIPR2

301

P41587
LLRSLLETNEIPSLI

WRNIP1

251

Q96S55
LRLAVTSLIPRIEKL

ZMYM6

1306

O95789
KSLQLVLEPSLQLLS

WNT1

51

P04628
VPLSLLLLIQALSVS

ZDHHC19

206

Q8WVZ1
TLTLPTSAKVLILVL

USP17L7

266

P0C7H9
QTARTLRILKIIPLN

SCN7A

206

Q01118
VVVRALIKTTLPTLN

SCN7A

1046

Q01118
NLVRLLTILLVSPIL

SLC9C2

346

Q5TAH2
NICTLSTIQKLPRLL

WIPI1

316

Q5MNZ9
IYSLTSKPILLLLAR

TTC27

151

Q6P3X3
SKPILLLLARIILVN

TTC27

156

Q6P3X3
LLLLPVLGLLVSSKT

RETN

6

Q9HD89
LNILLQTRSPEILVK

PPP1R10

51

Q96QC0
KLRVELLSASSLLPL

UNC13D

926

Q70J99
LTVADSLVILSKRIP

VN1R2

131

Q8NFZ6
SVFTILLPLLLRVLI

SLC16A10

211

Q8TF71
KRDLELLSSLLPQLT

KDM5C

1371

P41229
LSLLITTRPTALEKL

NLRP12

336

P59046